APR 20, 2016 2:56 PM PDT

New Treatment for Atherosclerosis Reduces Side Effects

WRITTEN BY: Kara Marker
For atherosclerosis patients who experience a wide range of side effects to cholesterol-lowering drugs, an alternate option would be life-changing. Although stemming from less than normal means, scientists from the University of Bonn have spent the last six years developing just the right alternate option.
 
Atherosclerosis is a form of heart disease where plaque buildup inside of the blood vessels limits the heart’s ability to pump oxygen and nutrients through the blood to the body’s tissues. Plaque is made up of fat, cholesterol, calcium, and other components that can come from a person’s diet (National Heart, Lung, and Blood Institute).
 
Current drugs for lowering cholesterol to treat atherosclerosis include statins, cholesterol absorption inhibitors, resins, and lipid-lowering therapies (American Heart Association). These drugs work in different way to reduce the amount of cholesterol clogging the blood vessels during atherosclerosis. For example, statins work by preventing formation of cholesterol in the liver.
 
Plaque inhibiting flow of blood in a vessel
 
A rare disease affecting twin females involved inhibiting their cells’ ability to remove cholesterol. In 2010, their mother pondered whether the drugs used to treat their condition, which cleared cholesterol crystals from cells, would be applicable to heart disease. Scientists from the University of Bonn were equally curious after the theory was brought to their attention, and the soon-to-be six-year study began.
 
With the study finally completed and published in Science Translational Medicine, scientists now introduce a drug called cyclodextrin, fresh from both mice and human tissue studies.
 
Cyclodextrin works by dissolving cholesterol crystals so they can more easily be removed by the body, plus the drug reduces the inflammatory response mounted by the immune system to reduce inflammation surrounding blood vessel walls.
 
Mice were fed a cholesterol-rich diet before receiving experimental cyclodextrin, and the drug both prevented future plaque formation as well as reduced existing plaque. Similarly, in human tissue, plaque biopsies obtained from human carotid arteries, researchers saw the removal of cholesterol as well as a “reprogramming” of macrophages to lessen their response to inflammation. With some macrophage activity freed up, these immune cells were able to contribute to the cause by picking up and ridding the vessels of cholesterol.
 
Next up? Funding for clinical trials in humans. Researchers from the University of Bonn are hopeful that cyclodextrin could be the next cholesterol-reducing drug on the market, producing fewer and less severe side effects than other medications.
 
 
Source: The Norwegian University of Science and Technology
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 14, 2021
Immunology
How Are Allergies Developed?
MAR 14, 2021
How Are Allergies Developed?
You might have experienced it yourself or met someone that can not eat a certain food or can not take a specific medicat ...
MAR 11, 2021
Immunology
Bye-Bye Burning: A New UTI Vaccine
MAR 11, 2021
Bye-Bye Burning: A New UTI Vaccine
Researchers have developed a vaccine that “trains” the bladder to fight back against the bacteria that cause ...
MAR 10, 2021
Genetics & Genomics
As Diphtheria Cases Rise & More Become Drug Resistant, It May Become a Threat
MAR 10, 2021
As Diphtheria Cases Rise & More Become Drug Resistant, It May Become a Threat
Diphtheria was once a leading cause of death for children; immunization programs eventually changed that for most countr ...
MAR 21, 2021
Cell & Molecular Biology
A Model of Early Human Development is Created
MAR 21, 2021
A Model of Early Human Development is Created
Scientists now have a new way to investigate the processes underlying human development, diseases that may arise during ...
MAR 26, 2021
Cell & Molecular Biology
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
MAR 26, 2021
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
For the many people waiting for transplants, 3D-printed organs can't come soon enough. Researchers have been making stri ...
APR 05, 2021
Drug Discovery & Development
Scientists Regenerate Missing Teeth in Mice
APR 05, 2021
Scientists Regenerate Missing Teeth in Mice
While most people have 32 teeth, around 1% of the population has more or fewer due to congenital reasons. Now, researche ...
Loading Comments...